mTOR Inhibition and Tuberous Sclerosis Prevention
Abstract
Investigators at Children's Memorial Health Institute, Warsaw, Poland, report monozygotic twin sisters with tuberous sclerosis complex (TSC), one treated with the mTOR inhibitor everolimus since age 4 years.
DOI: https://doi.org/10.15844/pedneurbriefs-27-9-8 | Journal eISSN: 2166-6482
Language: English
Page range: 70 - 71
Published on: Sep 1, 2013
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2013 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.